# Carcinoma, Intraductal trials recruiting: 21 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials with no drug phase for Carcinoma, Intraductal, Noninfiltrating that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Carcinoma, Intraductal, Noninfiltrating trials with no drug phase: 21 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/carcinoma-intraductal-noninfiltrating

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 21
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07940348 | Supine Versus Prone Whole-Breast Radiotherapy in Thai Women After Breast-Conserving Surgery | Mahidol University | Not applicable | Not yet recruiting | Breast Cancer, Ductal Carcinoma In Situ | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940348) |
| November 12, 2026 | NCT07934173 | Study of Oncology-Adapted Pain Reprocessing Therapy for Aromatase Inhibitor Associated Musculoskeletal Symptoms in Breast Cancer Survivors | University of Michigan Rogel Cancer Center | Not applicable | Not yet recruiting | Aromatase Inhibitor Therapy, Ductal Carcinoma in Situ, Hormone Receptor-positive Breast Cancer | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934173) |
| November 3, 2026 | NCT07911839 | Agentic AI App and Home Bioimpedance Monitoring for Endocrine Therapy Adherence and Lymphedema in Breast Cancer Survivors | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Breast Neoplasm Malignant Primary, Lymphedema Arm, Medication Adherence, Ductal Carcinoma In Situ | 264 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911839) |
| November 2, 2026 | NCT07909525 | Addressing Financial Hardship in AYA Cancer Survivors Through the Use of the New LIFT UP Intervention | ECOG-ACRIN Cancer Research Group | Not applicable | Not yet recruiting | Breast Ductal Carcinoma In Situ, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | 448 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909525) |
| July 17, 2026 | NCT07711847 | Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy | HeroSupport SA | Not applicable | Recruiting | Invasive Breast Cancer Early Stages, Ductal Carcinoma In Situ, DCIS | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711847) |
| April 22, 2026 | NCT07544134 | Areola Preservation in NSM With Nipple Involvement | Second Affiliated Hospital, Zhejiang University, School of Medicine | Not applicable | Not yet recruiting | Breast Cancer, Ductal Carcinoma In Situ, DCIS, Invasive Breast Carcinoma | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07544134) |
| April 14, 2026 | NCT07527468 | HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery | Hôpital du Valais | Not applicable | Not yet recruiting | Breast Cancer, Ductal Carcinoma In Situ, Invasive Lobular Carcinoma, Breast Neoplasm Female | 228 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07527468) |
| December 18, 2025 | NCT07292246 | A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study) | Sponsor not shown (see the record) | Not applicable | Recruiting | Breast Cancer, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, Hereditary Breast Carcinoma, Breast Neoplasms, DCIS... | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07292246) |
| November 24, 2025 | NCT07245316 | Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Ductal Carcinoma in Situ of the Breast | 340 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07245316) |
| July 31, 2025 | NCT07095114 | A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients. | Barbara Ann Karmanos Cancer Institute | Not applicable | Recruiting | Ductal Carcinoma in Situ, Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07095114) |
| July 11, 2025 | NCT07060599 | Human-AI Collaborative INSIGHT Diagnostic Workflow for in Breast Cancer With Extensive Intraductal Component | Sun Yat-sen University | Not applicable | Not yet recruiting | Artificial Intelligence (AI) in Diagnosis | 480 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07060599) |
| March 30, 2025 | NCT06903468 | Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the... | University of Florida | Not applicable | Recruiting | Ductal Carcinoma in Situ, Breast Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06903468) |
| March 5, 2025 | NCT06860217 | Robotic Nipple Sparing Mastectomy with Immediate Reconstruction | European Institute of Oncology | Not applicable | Not yet recruiting | Breast Cancer, DCIS, BRCA Mutation | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06860217) |
| April 5, 2024 | NCT06350500 | A Patient Navigation Program for Addressing Disparities in Breast Cancer Care | Roswell Park Cancer Institute | Not applicable | Recruiting | Breast Carcinoma, Breast Ductal Carcinoma in Situ | 126 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06350500) |
| January 22, 2024 | NCT06217458 | The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS | Clinical Hospital Center Rijeka | Not applicable | Not yet recruiting | DCIS, Breast Carcinoma in Situ, Calcification | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06217458) |
| June 22, 2023 | NCT05912569 | Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS | Seoul National University Hospital | Not applicable | Recruiting | DCIS | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05912569) |
| July 13, 2021 | NCT04959474 | Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer | Thomas Jefferson University | Not applicable | Recruiting | Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, Anatomic Stage 2 Breast Cancer AJCC v8... | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04959474) |
| July 31, 2020 | NCT04494945 | Identifying and Caring for Individuals With Inherited Cancer Syndrome | OHSU Knight Cancer Institute | Not applicable | Recruiting | BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome, Breast Ductal Carcinoma In Situ, Hematopoietic and... | 27,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04494945) |
| April 10, 2019 | NCT03909282 | Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma | Stanford University | Not applicable | Recruiting | Ductal Breast Carcinoma in Situ | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03909282) |
| September 29, 2016 | NCT02918474 | Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer | M.D. Anderson Cancer Center | Not applicable | Recruiting | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC... | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02918474) |
| December 3, 2015 | NCT02620852 | Women Informed to Screen Depending on Measures of Risk (Wisdom Study) | University of California, San Francisco | Not applicable | Recruiting | Breast Cancer Screening, Breast Carcinoma in Situ, Breast Cancer | 100,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02620852) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| European Institute of Oncology | 1 |
| Hôpital du Valais | 1 |
| Seoul National University Hospital | 1 |
| Roswell Park Cancer Institute | 1 |
| Clinical Hospital Center Rijeka | 1 |
| HeroSupport SA | 1 |
| M.D. Anderson Cancer Center | 1 |
| Stanford University | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| University of Michigan Rogel Cancer Center | 1 |
| ECOG-ACRIN Cancer Research Group | 1 |
| Sun Yat-sen University | 1 |
| Mahidol University | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Thomas Jefferson University | 1 |
| University of California, San Francisco | 1 |
| University of Florida | 1 |
| OHSU Knight Cancer Institute | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 9 |
| South Korea | 3 |
| China | 2 |
| Italy | 1 |
| Switzerland | 1 |
| Croatia | 1 |
| Greece | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Wine bars in the United States](https://specstream.ai/data/businesses/wine-bars/united-states)
- [Language schools in the United States](https://specstream.ai/data/businesses/language-schools/united-states)
- [Bakeries in the United States](https://specstream.ai/data/businesses/bakeries/united-states)
- [Otology practices in the United States](https://specstream.ai/data/businesses/otology-practices/united-states)
- [Colombian restaurants in the United States](https://specstream.ai/data/businesses/colombian-restaurants/united-states)
- [Refinishing companies in the United States](https://specstream.ai/data/businesses/refinishing-companies/united-states)
